CIMG Inc. (CIMG): Nasdaq/NYSE listing notice — CIMG receives additional delisting notice from Nasdaq for late 10-K filing

CIMG Inc.

Nasdaq notified CIMG on Jan 22, 2026, of non-compliance with Listing Rule 5250(c)(1) due to failure to file Annual Report (Form 10-K) for FY ended Sep 30, 2025.
The Nasdaq Hearings Panel will consider this as an additional basis for potential delisting.
CIMG remains under a Mandatory Panel Monitor through Nov 14, 2026, imposed on Dec 4, 2025.
The notice does not immediately affect listing or trading; stock continues under symbol 'IMG'.
Company states it is working diligently to complete and file the Form 10-K as soon as practicable.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

CIMG Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

January 22, 2026, CIMG Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) will consider an additional basis for the potential delisting of the Company’s securities from The Nasdaq Capital Market during the its panel monitor period because the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended September 30, 2025. In a decision letter dated December 4, 2025, the Panel imposed a Mandatory Panel Mo

View on SEC.gov

Browse all listing & compliance notices →

CIMG Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-004031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.